{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:19:13Z","timestamp":1794071953243,"version":"4.8.0"},"reference-count":117,"publisher":"Walter de Gruyter GmbH","issue":"8","funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"crossref","award":["NS111316"],"award-info":[{"award-number":["NS111316"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NICHD","award":["P50-HD103557"],"award-info":[{"award-number":["P50-HD103557"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Huntington\u2019s disease (HD) is a genetic, inexorably fatal neurodegenerative disease. Patient average survivability is up to 20 years after the onset of symptoms. Those who suffer from the disease manifest motor, cognitive, and psychiatric impairments. There is indirect evidence suggesting that omega-3 polyunsaturated fatty acids (\u03c9-3 PUFA) could have alleviating effects on most of HD symptoms. These include beneficial effects against cachexia and weight loss, decrease of cognitive impairment over time, and improvement of psychiatric symptoms such as depression and irritability. Furthermore, there is a positive correlation between consumption of \u03c9-3 PUFAs in diets and prevalence of HD, as well as direct effects on the disease<jats:italic>via<\/jats:italic>release of serotonin. Unfortunately, to date, very few studies have examined the effects of \u03c9-3 PUFAs in HD, both on the symptoms and on disease progression. This paper reviews evidence in the literature suggesting that \u03c9-3 PUFAs can be used in neurodegenerative disorders. This information can be extrapolated to support further research of \u03c9-3 PUFAs and their potential use for HD treatment.<\/jats:p>","DOI":"10.1515\/revneuro-2021-0013","type":"journal-article","created":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T08:42:34Z","timestamp":1617612154000},"page":"871-886","source":"Crossref","is-referenced-by-count":8,"title":["Converging evidence in support of omega-3 polyunsaturated fatty acids as a potential therapy for Huntington\u2019s disease symptoms"],"prefix":"10.1515","volume":"32","author":[{"given":"Owen M.","family":"Vega","sequence":"first","affiliation":[{"name":"Intellectual and Developmental Disabilities Research Center, Jane and Terry Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine, University of California Los Angeles , 760 Westwood Plaza , Los Angeles , CA 90095 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cepeda","sequence":"additional","affiliation":[{"name":"Intellectual and Developmental Disabilities Research Center, Jane and Terry Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine, University of California Los Angeles , 760 Westwood Plaza , Los Angeles , CA 90095 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,4,5]]},"reference":[{"key":"2023040102434497658_j_revneuro-2021-0013_ref_001","doi-asserted-by":"crossref","unstructured":"Arterburn, L.M., Hall, E.B., and Oken, H. (2006). Distribution, interconversion, and dose response of \u03c9-3 fatty acids in humans. Am. J.\u00a0Clin. Nutr. 83: 1467S\u20131476S.","DOI":"10.1093\/ajcn\/83.6.1467S"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_002","doi-asserted-by":"crossref","unstructured":"Aryal, S., Hussain, S., Drevon, C.A., Nagelhus, E., Hvalby, \u00d8., Jensen, V., Walaas, S.I., and Davanger, S. (2019). Omega-3 fatty acids regulate plasticity in distinct hippocampal glutamatergic synapses. Eur. J.\u00a0Neurosci. 49: 40\u201350.","DOI":"10.1111\/ejn.14224"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_003","doi-asserted-by":"crossref","unstructured":"Avallone, R., Vitale, G., and Bertolotti, M. (2019). Omega-3 fatty acids and neurodegenerative diseases: new evidence in clinical trials. Int. J.\u00a0Mol. Sci. 20: 4256.","DOI":"10.3390\/ijms20174256"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_004","doi-asserted-by":"crossref","unstructured":"Aziz, N.A., Van Der Burg, J.M.M., Landwehrmeyer, G.B., Brundin, P., Stijnen, T., and Roos, R.A.C. (2008a). Weight loss in Huntington disease increases with higher CAG repeat number. Neurology 71: 1506\u20131513.","DOI":"10.1212\/01.wnl.0000334276.09729.0e"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_005","doi-asserted-by":"crossref","unstructured":"Aziz, N.A., Van Der Marck, M.A., Pijl, H., Olde Rikkert, M.G.M., Bloem, B.R., and Roos, R.A.C. (2008b). Weight loss in neurodegenerative disorders. J.\u00a0Neurol. 255: 1872\u20131880.","DOI":"10.1007\/s00415-009-0062-8"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_006","doi-asserted-by":"crossref","unstructured":"Bachoud-L\u00e9vi, A.C., Ferreira, J., Massart, R., Youssov, K., Rosser, A., Busse, M., Craufurd, D., Reilmann, R., De Michele, G., Rae, D., et al.. (2019). International guidelines for the treatment of Huntington\u2019s disease. Front. Neurol. 10: 710.","DOI":"10.3389\/fneur.2019.00710"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_007","doi-asserted-by":"crossref","unstructured":"Bai, Z.G., Bo, A., Wu, S.J., Gai, Q.Y., and Chi, I. (2018). Omega-3 polyunsaturated fatty acids and reduction of depressive symptoms in older adults: a systematic review and meta-analysis. J.\u00a0Affect. Disord. 241: 241\u2013248.","DOI":"10.1016\/j.jad.2018.07.057"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_008","doi-asserted-by":"crossref","unstructured":"Baine, F.K., Kay, C., Ketelaar, M.E., Collins, J.A., Semaka, A., Doty, C.N., Krause, A., Jacquie Greenberg, L., and Hayden, M.R. (2013). Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes. Eur. J.\u00a0Hum. Genet. 21: 1120\u20131127.","DOI":"10.1038\/ejhg.2013.2"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_009","doi-asserted-by":"crossref","unstructured":"Bazan, N.G. (2009). Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot. Essent. Fatty Acids 81: 205\u2013211.","DOI":"10.1016\/j.plefa.2009.05.024"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_010","doi-asserted-by":"crossref","unstructured":"Bazan, N.G. (2019). Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection. Mol. Aspect. Med. 64: 18\u201333.","DOI":"10.1016\/j.mam.2018.09.003"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_011","doi-asserted-by":"crossref","unstructured":"Bazinet, R.P. and Lay\u00e9, S. (2014). Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 15: 771\u2013785, https:\/\/doi.org\/10.1038\/nrn3820.","DOI":"10.1038\/nrn3820"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_012","doi-asserted-by":"crossref","unstructured":"Behrouzian, B. and Buist, P.H. (2003). Mechanism of fatty acid desaturation: a bioorganic perspective. Prostaglandins Leukot. Essent. Fatty Acids 68: 107\u2013112.","DOI":"10.1016\/S0952-3278(02)00260-0"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_013","doi-asserted-by":"crossref","unstructured":"Beltz, B.S., Tlusty, M.F., Benton, J.L., and Sandeman, D.C. (2007). Omega-3 fatty acids upregulate adult neurogenesis. Neurosci. Lett. 415: 154\u2013158.","DOI":"10.1016\/j.neulet.2007.01.010"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_014","doi-asserted-by":"crossref","unstructured":"Bi, J., Chen, C., Sun, P., Tan, H., Feng, F., and Shen, J. (2019). Neuroprotective effect of omega-3 fatty acids on spinal cord injury induced rats. Brain Behav. 9: e01339.","DOI":"10.1002\/brb3.1339"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_015","unstructured":"Bianchi, V.E., Herrera, P.F., and Laura, R. (2019). Effect of nutrition on neurodegenerative diseases. A systematic review. Nutr. Neurosci. 1\u201325."},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_016","doi-asserted-by":"crossref","unstructured":"Block, R.C., Dorsey, E.R., Beck, C.A., Brenna, J.T., and Shoulson, I. (2010). Altered cholesterol and fatty acid metabolism in Huntington disease. J.\u00a0Clin. Lipidol. 4: 17\u201323.","DOI":"10.1016\/j.jacl.2009.11.003"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_017","doi-asserted-by":"crossref","unstructured":"Bo, Y., Zhang, X., Wang, Y., You, J., Cui, H., Zhu, Y., Pang, W., Liu, W., Jiang, Y., and Lu, Q. (2017). The \u03c9-3 polyunsaturated fatty acids supplementation improved the cognitive function in the Chinese elderly with mild cognitive impairment: a double-blind randomized controlled trial. Nutrients 9: 54.","DOI":"10.3390\/nu9010054"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_018","doi-asserted-by":"crossref","unstructured":"Brotherton, A., Campos, L., Rowell, A., Zoia, V., Simpson, S.A., and Rae, D. (2012). Nutritional management of individuals with Huntington\u2019s disease: nutritional guidelines. Neurodegener. Dis. Manag. 2.","DOI":"10.2217\/nmt.11.69"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_019","doi-asserted-by":"crossref","unstructured":"Calon, F., Lim, G.P., Morihara, T., Yang, F., Ubeda, O., Salem, N.Jr, Frautschy, S.A., and Cole, G.M. (2005). Dietary \u03c9-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer\u2019s disease. Eur. J.\u00a0Neurosci. 22: 617\u2013626.","DOI":"10.1111\/j.1460-9568.2005.04253.x"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_020","doi-asserted-by":"crossref","unstructured":"Calviello, G., Su, H.M., Weylandt, K.H., Fasano, E., Serini, S., and Cittadini, A. (2013). Experimental evidence of \u03c9-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases. BioMed Res. Int. 2013: 743171.","DOI":"10.1155\/2013\/743171"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_021","doi-asserted-by":"crossref","unstructured":"Castilhos, R.M., Augustin, M.C., Santos, J.A., Perandones, C., Saraiva-Pereira, M.L., Jardim, L.B., and Neurogen\u00e9tica, R. (2016). Genetic aspects of Huntington\u2019s disease in Latin America. A systematic review. Clin. Genet. 89: 295\u2013303.","DOI":"10.1111\/cge.12641"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_022","unstructured":"Cangemi, C.F. and Miller, R.J. (1998). Huntington\u2019s disease: review and anesthetic case management. Anesth. Prog. 45: 150\u2013153."},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_023","doi-asserted-by":"crossref","unstructured":"Cardoso, C., Afonso, C., and Bandarra, N. (2016). Dietary DHA and health: cognitive function ageing. Nutr. Res. Rev. 29: 281\u2013294.","DOI":"10.1017\/S0954422416000184"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_024","doi-asserted-by":"crossref","unstructured":"Carreira, J.C., Jahanshahi, A., Zeef, D., Kocabicak, E., Vlamings, R., von H\u00f6rsten, S., and Temel, Y. (2015). Transgenic rat models of Huntington\u2019s disease. Curr. Top Behav. Neurosci. 22: 135\u2013147.","DOI":"10.1007\/7854_2013_245"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_025","doi-asserted-by":"crossref","unstructured":"Carrie, I., Abelan Van Kan, G., Rolland, Y., Gillete-Guyonnet, S., and Vellas, B. (2009). PUFA for prevention and treatment of dementia? Curr. Pharmaceut. Des. 15: 4173\u20134185.","DOI":"10.2174\/138161209789909764"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_026","doi-asserted-by":"crossref","unstructured":"Cepeda, C., Cummings, D.M., Andr\u00e9, V.M., Holley, S.M., and Levine, M.S. (2010). Genetic mouse models of Huntington\u2019s disease: focus on electrophysiological mechanisms. ASN Neuro 2: e00033.","DOI":"10.1042\/AN20090058"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_027","doi-asserted-by":"crossref","unstructured":"Cepeda, C., and Levine, M.S. (2020). Synaptic dysfunction in Huntington\u2019s disease: lessons from genetic animal models. Neuroscientist, https:\/\/doi.org\/10.1177\/1073858420972662 (Epub ahead of print).","DOI":"10.1177\/1073858420972662"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_028","doi-asserted-by":"crossref","unstructured":"Chew, H., Solomon, V.A., and Fonteh, A.N. (2020). Involvement of lipids in Alzheimer\u2019s disease pathology and potential therapies. Front. Physiol. 11: 598.","DOI":"10.3389\/fphys.2020.00598"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_029","doi-asserted-by":"crossref","unstructured":"Chitre, N.M., Moniri, N.H., and Murnane, K.S. (2019). Omega-3 fatty acids as druggable therapeutics for neurodegenerative disorders. CNS Neurol. Disord. Drug Targets 18: 735\u2013749.","DOI":"10.2174\/1871527318666191114093749"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_030","doi-asserted-by":"crossref","unstructured":"Christodoulou, C.C., Zamba-Papanicolaou, E., and Demetriou, C.A. (2020). Dietary intake, mediterranean diet adherence and caloric intake in Huntington\u2019s disease: a review. Nutrients 12: 2946.","DOI":"10.3390\/nu12102946"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_031","doi-asserted-by":"crossref","unstructured":"Cook, R.L., Parker, H.M., Donges, C.E., O\u2019Dwyer, N.J., Cheng, H.L., Steinbeck, K.S., Cox, E.P., Franklin, J.L., Garg, M.L., and O\u2019Connor, H.T. (2019). Omega-3 polyunsaturated fatty acids status and cognitive function in young women. Lipids Health Dis. 18.","DOI":"10.1186\/s12944-019-1143-z"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_032","unstructured":"Coyle, J.T. (1979). An animal model for Huntington\u2019s disease. Biol. Psychiatr. 14: 251\u2013276."},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_033","doi-asserted-by":"crossref","unstructured":"Cutuli, D. (2017). Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging. Curr. Neuropharmacol. 15: 534\u2013542.","DOI":"10.2174\/1570159X14666160614091311"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_034","doi-asserted-by":"crossref","unstructured":"De Lau, L.M.L., Bornebroek, M., Witteman, J.C.M., Hofman, A., Koudstaal, P.J., and Breteler, M.M.B. (2005). Dietary fatty acids and the risk of Parkinson disease: the Rotterdam Study. Neurology 64: 2040\u20132045.","DOI":"10.1212\/01.WNL.0000166038.67153.9F"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_035","doi-asserted-by":"crossref","unstructured":"Dickey, A.S. and La Spada, A.R. (2018). Therapy development in Huntington disease: from current strategies to emerging opportunities. Am. J.\u00a0Med. Genet. A 176: 842\u2013861.","DOI":"10.1002\/ajmg.a.38494"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_036","doi-asserted-by":"crossref","unstructured":"Dyall, S.C. (2015). Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front. Aging Neurosci. 7: 52.","DOI":"10.3389\/fnagi.2015.00052"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_037","doi-asserted-by":"crossref","unstructured":"Eckert, G.P., Lipka, U., and Muller, W.E. (2013). Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria. Prostaglandins Leukot. Essent. Fatty Acids 88: 105\u2013114.","DOI":"10.1016\/j.plefa.2012.05.006"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_038","doi-asserted-by":"crossref","unstructured":"Ehrnhoefer, D.E., Butland, S.L., Pouladi, M.A., and Hayden, M.R. (2009). Mouse models of Huntington disease: variations on a theme. Dis. Model Mech. 2: 123\u2013129.","DOI":"10.1242\/dmm.002451"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_039","doi-asserted-by":"crossref","unstructured":"Ehrnhoefer, D.E., Martin, D., Schmidt, M.E., Qiu, X., Ladha, S., Caron, N.S., Skotte, N.H., Nguyen, Y., Vaid, K., Southwell, A.L., et al.. (2018). Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease. Acta Neuropathol. Commun. 6: 16.","DOI":"10.1186\/s40478-018-0518-0"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_040","unstructured":"Erdman, J., Oria, M., and Pillsbury, L. (2011). Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In: Nutrition and traumatic brain injury: improving acute and subacute health outcomes in military personnel. National Academies Press, Washington, D.C., USA, pp. 188\u2013204."},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_041","doi-asserted-by":"crossref","unstructured":"Evans, W.J., Morley, J.E., Argil\u00e9s, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al.. (2008). Cachexia: a new definition. Clin. Nutr. 27: 793\u2013799.","DOI":"10.1016\/j.clnu.2008.06.013"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_042","doi-asserted-by":"crossref","unstructured":"Exuzides, A., Crowell, V., Reddy, S.R., Chang, E., and Yohrling, G. (2020). Epidemiology of Huntington\u2019s disease (HD) in the US medicare population (670). Neurology 94.","DOI":"10.1212\/WNL.94.15_supplement.670"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_043","doi-asserted-by":"crossref","unstructured":"Ferrante, R.J. (2009). Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials. Biochim. Biophys. Acta 1792: 506\u2013520.","DOI":"10.1016\/j.bbadis.2009.04.001"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_044","doi-asserted-by":"crossref","unstructured":"Firl\u0105g, M., Kamaszewski, M., Gaca, K., Adamek, D., and Ba\u0142asi\u0144ska, B. (2013). The neuroprotective effect of long-term \u03c9-3 polyunsaturated fatty acids supplementation in the cerebral cortex and hippocampus of aging rats. Folia Neuropathol. 51: 235\u2013242.","DOI":"10.5114\/fn.2013.37708"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_045","doi-asserted-by":"crossref","unstructured":"Gabbay, V., Freed, R.D., Alonso, C.M., Senger, S., Stadterman, J., Davison, B.A., and Klein, R.G. (2018). A double-blind placebo-controlled trial of omega-3 fatty acids as a monotherapy for adolescent depression. J.\u00a0Clin. Psychiatr. 79: 17m11596.","DOI":"10.4088\/JCP.17m11596"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_046","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Guevara, E., C\u00e1rdenas, G., P\u00e9rez-Severiano, F., and Mart\u00ednez-Lazcano, J.C. (2020). Dysregulated brain cholesterol metabolism is linked to neuroinflammation in Huntington\u2019s disease. Mov. Disord. 35: 1113\u20131127.","DOI":"10.1002\/mds.28089"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_047","doi-asserted-by":"crossref","unstructured":"Gray, M., Shirasaki, D.I., Cepeda, C., Andre, V.M., Wilburn, B., Lu, X.H., Tao, J., Yamazaki, I., Li, S.H., Sun, Y.E., et al.. (2008). Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J.\u00a0Neurosci. 28: 6182\u20136195.","DOI":"10.1523\/JNEUROSCI.0857-08.2008"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_048","doi-asserted-by":"crossref","unstructured":"Grosso, G., Micek, A., Marventano, S., Castellano, S., Mistretta, A., Pajak, A., and Galvano, F. (2016). Dietary \u03c9-3 PUFA, fish consumption and depression: a systematic review and meta-analysis of observational studies. J.\u00a0Affect. Disord. 205: 269\u2013281.","DOI":"10.1016\/j.jad.2016.08.011"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_049","doi-asserted-by":"crossref","unstructured":"Hatami, A., Zhu, C., Rela\u00f1o-Gines, A., Elias, C., Galstyan, A., Jun, M., Milne, G., Cantor, C.R., Chesselet, M.F., and Shchepinov, M.S. (2018). Deuterium-reinforced linoleic acid lowers lipid peroxidation and mitigates cognitive impairment in the Q140 knock in mouse model of Huntington\u2019s disease. FEBS J. 285: 3002\u20133012.","DOI":"10.1111\/febs.14590"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_050","doi-asserted-by":"crossref","unstructured":"He, Y., Suofu, Y., Yablonska, S., Wang, X., Larkin, T.M., Kim, J., Carlisle, D.L., and Friedlander, R.M. (2019). Increased serotonin transporter expression in Huntington\u2019s disease patients is not consistently replicated in murine models. J.\u00a0Huntingtons Dis. 8: 449\u2013457.","DOI":"10.3233\/JHD-180318"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_051","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Echeagaray, E., Gonz\u00e1lez, N., Ruelas, A., Mendoza, E., Rodr\u00edguez-Mart\u00ednez, E., and Antuna-Bizarro, R. (2011). Low doses of 3-nitropropionic acid in vivo induce damage in mouse skeletal muscle. Neurol. Sci. 32: 241\u2013254.","DOI":"10.1007\/s10072-010-0394-2"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_052","doi-asserted-by":"crossref","unstructured":"Holmans, P.A., Massey, T.H., and Jones, L. (2017). Genetic modifiers of Mendelian disease: Huntington\u2019s disease and the trinucleotide repeat disorders. Hum. Mol. Genet. 26: R83\u2013R90.","DOI":"10.1093\/hmg\/ddx261"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_053","doi-asserted-by":"crossref","unstructured":"Hult, S., Soylu, R., Bj\u00f6rklund, T., Belgardt, B.F., Mauer, J., Br\u00fcning, J.C., Kirik, D., and Peters\u00e9n, \u00c5. (2011). Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits. Cell Metabol. 13: 428\u2013439.","DOI":"10.1016\/j.cmet.2011.02.013"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_054","doi-asserted-by":"crossref","unstructured":"Jackson, P.A., Reay, J.L., Scholey, A.B., and Kennedy, D.O. (2012). Docosahexaenoic acid-rich fish oil modulates the cerebral hemodynamic response to cognitive tasks in healthy young adults. Biol. Psychol. 89: 183\u2013190.","DOI":"10.1016\/j.biopsycho.2011.10.006"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_055","doi-asserted-by":"crossref","unstructured":"Karagas, N.E., Rocha, N.P., and Stimming, E.F. (2020). Irritability in Huntington\u2019s disease. J.\u00a0Huntingtons Dis. 9: 107\u2013113.","DOI":"10.3233\/JHD-200397"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_056","doi-asserted-by":"crossref","unstructured":"Lange, K.W. (2020). Lipids in the treatment of neurodegerative diseases. Bailey\u2019s Ind. Oil Fat Prod. 1\u201317.","DOI":"10.1002\/047167849X.bio118"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_057","doi-asserted-by":"crossref","unstructured":"Lange, K.W. (2020). Omega-3 fatty acids and mental health. Glob. Health J. 4: 18\u201330.","DOI":"10.1016\/j.glohj.2020.01.004"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_058","doi-asserted-by":"crossref","unstructured":"Liu, Y.H., Li, X.Y., Chen, C.Y., Zhang, H.M., and Kang, J.X. (2015). Omega-3 fatty acid intervention suppresses lipopolysaccharide-induced inflammation and weight loss in mice. Mar. Drugs 13: 1026\u20131036.","DOI":"10.3390\/md13021026"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_059","doi-asserted-by":"crossref","unstructured":"Luchtman, D.W., Meng, Q., and Song, C. (2012). Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson\u2019s disease. Behav. Brain Res. 226: 386\u2013396.","DOI":"10.1016\/j.bbr.2011.09.033"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_060","doi-asserted-by":"crossref","unstructured":"Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W., et al.. (1996). Exon I of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493\u2013506.","DOI":"10.1016\/S0092-8674(00)81369-0"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_061","doi-asserted-by":"crossref","unstructured":"Mazahery, H., Conlon, C.A., Beck, K.L., Mugridge, O., Kruger, M.C., Stonehouse, W., Camargo, C.A., Meyer, B.J., Jones, B., and von Hurst, P.R. (2019). A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder. J.\u00a0Steroid Biochem. Mol. Biol. 187: 9\u201316.","DOI":"10.1016\/j.jsbmb.2018.10.017"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_062","doi-asserted-by":"crossref","unstructured":"McColgan, P. and Tabrizi, S.J. (2018). Huntington\u2019s disease: a clinical review. Eur. J.\u00a0Neurol. 25: 24\u201334.","DOI":"10.1111\/ene.13413"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_063","doi-asserted-by":"crossref","unstructured":"Menalled, L.B. (2005). Knock-in mouse models of Huntington\u2019s disease. NeuroRx 2: 465\u2013470.","DOI":"10.1602\/neurorx.2.3.465"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_064","doi-asserted-by":"crossref","unstructured":"Meng, Q.J., Luchtman, D.W., El Bahh, B., Zidichouski, J.A., Yang, J., and Song, C. (2010). Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices. Eur. J.\u00a0Pharmacol. 649: 127\u2013134.","DOI":"10.1016\/j.ejphar.2010.09.046"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_065","doi-asserted-by":"crossref","unstructured":"Mielcarek, M. and Isalan, M. (2015). A shared mechanism of muscle wasting in cancer and Huntington\u2019s disease. Clin. Transl. Med. 4: 34.","DOI":"10.1186\/s40169-015-0076-z"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_066","doi-asserted-by":"crossref","unstructured":"Mischoulon, D. and Freeman, M.P. (2013). Omega-3 fatty acids in psychiatry. Psychiatr. Clin. 36: 15\u201323.","DOI":"10.1016\/j.psc.2012.12.002"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_067","doi-asserted-by":"crossref","unstructured":"Munro, I.A. and Garg, M.L. (2012). Dietary supplementation with n \u03c9-3 PUFA does not promote weight loss when combined with a very-low-energy diet. Br. J.\u00a0Nutr. 108: 1466\u20131474.","DOI":"10.1017\/S0007114511006817"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_068","doi-asserted-by":"crossref","unstructured":"Munro, I.A. and Garg, M.L. (2013). Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults. Obes. Res. Clin. Pract. 7: 173\u2013181.","DOI":"10.1016\/j.orcp.2011.11.001"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_069","doi-asserted-by":"crossref","unstructured":"Murphy, R.A., Yeung, E., Mazurak, V.C., and Mourtzakis, M. (2011). Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br. J.\u00a0Canc. 105: 1469\u20131473.","DOI":"10.1038\/bjc.2011.391"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_070","doi-asserted-by":"crossref","unstructured":"Nabavi, S.F., Bilotto, S., Russo, G.L., Orhan, I.E., Habtemariam, S., Daglia, M., Devi, K.P., Loizzo, M.R., Tundis, R., and Nabavi, S.M. (2015). Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. Canc. Metastasis Rev. 34: 359\u2013380.","DOI":"10.1007\/s10555-015-9572-2"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_071","doi-asserted-by":"crossref","unstructured":"Nance, M.A. (2017). Genetics of Huntington disease. Handb. Clin. Neurol. 144: 3\u201314.","DOI":"10.1016\/B978-0-12-801893-4.00001-8"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_072","doi-asserted-by":"crossref","unstructured":"Nasir, M. and Bloch, M.H. (2019). Trim the fat: the role of omega-3 fatty acids in psychopharmacology. Ther. Adv. Psychopharmacol. 9: 2045125319869791.","DOI":"10.1177\/2045125319869791"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_073","doi-asserted-by":"crossref","unstructured":"Nooyens, A.C.J., van Gelder, B.M., Bueno-de-Mesquita, H.B., van Boxtel, M.P.J., and Verschuren, W.M.M. (2018). Fish consumption, intake of fats and cognitive decline at middle and older age: the Doetinchem Cohort Study. Eur. J.\u00a0Nutr. 57: 1667\u20131675.","DOI":"10.1007\/s00394-017-1453-8"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_074","unstructured":"Olivera-Pueyo, J. and Pelegr\u00edn-Valero, C. (2017). Dietary supplements for cognitive impairment. Actas Esp. Psiquiatr. 45: 37\u201347."},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_075","doi-asserted-by":"crossref","unstructured":"Paoli, R.A., Botturi, A., Ciammola, A., Silani, V., Prunas, C., Lucchiari, C., Zugno, E., and Caletti, E. (2017). Neuropsychiatric burden in Huntington\u2019s disease. Brain Sci. 7: 67.","DOI":"10.3390\/brainsci7060067"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_076","doi-asserted-by":"crossref","unstructured":"Patrick, R.P. and Ames, B.N. (2015). Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 29: 2207\u20132222.","DOI":"10.1096\/fj.14-268342"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_077","doi-asserted-by":"crossref","unstructured":"Paulsen, J.S. (2011). Cognitive impairment in Huntington disease: diagnosis and treatment. Curr. Neurol. Neurosci. Rep. 11: 474\u2013483.","DOI":"10.1007\/s11910-011-0215-x"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_078","doi-asserted-by":"crossref","unstructured":"Phan, J., Hickey, M.A., Zhang, P., Chesselet, M.F., and Reue, K. (2009). Adipose tissue dysfunction tracks disease progression in two Huntington\u2019s disease mouse models. Hum. Mol. Genet. 18: 1006\u20131016.","DOI":"10.1093\/hmg\/ddn428"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_079","doi-asserted-by":"crossref","unstructured":"Quigley, J. (2017). Juvenile Huntington\u2019s disease: diagnostic and treatment considerations for the psychiatrist. Curr. Psychiatr. Rep. 19: 9.","DOI":"10.1007\/s11920-017-0759-9"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_080","doi-asserted-by":"crossref","unstructured":"Raclot, T., Groscolas, R., Langin, D., and Ferr\u00e9, P. (1997). Site-specific regulation of gene expression by \u03c9-3 polyunsaturated fatty acids in rat white adipose tissues. J.\u00a0Lipid Res. 38: 1963\u20131972.","DOI":"10.1016\/S0022-2275(20)37127-3"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_081","doi-asserted-by":"crossref","unstructured":"Rasmussen, A., Macias, R., Yescas, P., Ochoa, A., Davila, G., and Alonso, E. (2000). Huntington disease in children: genotype-phenotype correlation. Neuropediatrics 31: 190\u2013194.","DOI":"10.1055\/s-2000-7461"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_082","doi-asserted-by":"crossref","unstructured":"Ruzickova, J., Rossmeisl, M., Prazak, T., Flachs, P., Sponarova, J., Vecka, M., Tvrzicka, E., Bryhn, M., and Kopecky, J. (2004). Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39: 1177\u20131185.","DOI":"10.1007\/s11745-004-1345-9"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_083","doi-asserted-by":"crossref","unstructured":"Sathyasaikumar, K.V., Stachowski, E.K., Amori, L., Guidetti, P., Muchowski, P.J., and Schwarcz, R. (2010). Dysfunctional kynurenine pathway metabolism in the R6\/2 mouse model of Huntington\u2019s disease. J.\u00a0Neurochem. 113: 1416\u20131425.","DOI":"10.1111\/j.1471-4159.2010.06675.x"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_084","doi-asserted-by":"crossref","unstructured":"Schwarcz, R., Whetsell, W.O., and Mangano, R.M. (1983). Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219: 316\u2013318.","DOI":"10.1126\/science.6849138"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_085","doi-asserted-by":"crossref","unstructured":"Simopoulos, A.P. (2002). The importance of the ratio of omega-6\/omega-3 essential fatty acids. Biomed. Pharmacother. 56: 365\u2013379.","DOI":"10.1016\/S0753-3322(02)00253-6"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_086","doi-asserted-by":"crossref","unstructured":"Simopoulos, A.P. (2006). Evolutionary aspects of diet, the omega-6\/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60: 502\u2013507.","DOI":"10.1016\/j.biopha.2006.07.080"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_087","doi-asserted-by":"crossref","unstructured":"Slow, E.J., van Raamsdonk, J., Rogers, D., Coleman, S.H., Graham, R.K., Deng, Y., Oh, R., Bissada, N., Hossain, S.M., Yang, Y.Z., et al.. (2003). Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12: 1555\u20131567.","DOI":"10.1093\/hmg\/ddg169"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_088","doi-asserted-by":"crossref","unstructured":"Smith, G.I., Julliand, S., Reeds, D.N., Sinacore, D.R., Klein, S., and Mittendorfer, B. (2015). Fish oil-derived \u03c9-3 PUFA therapy increases muscle mass and function in healthy older adults. Am. J.\u00a0Clin. Nutr. 102: 115\u2013122.","DOI":"10.3945\/ajcn.114.105833"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_089","doi-asserted-by":"crossref","unstructured":"Snowden, J.S. (2017). The neuropsychology of Huntington\u2019s disease. Arch. Clin. Neuropsychol. 1: 876\u2013887.","DOI":"10.1093\/arclin\/acx086"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_090","doi-asserted-by":"crossref","unstructured":"Solfrizzi, V., Frisardi, V., Capurso, C., D\u2019Introno, A., Colacicco, A.M., Vendemiale, G., Capurso, A., and Panza, F. (2010). Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms. Ageing Res. Rev. 9: 184\u2013199.","DOI":"10.1016\/j.arr.2009.07.005"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_091","doi-asserted-by":"crossref","unstructured":"Stark, K.D., Van Elswyk, M.E., Higgins, M.R., Weatherford, C.A., and Salem, N. (2016). Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog. Lipid Res. 63: 132\u2013152.","DOI":"10.1016\/j.plipres.2016.05.001"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_092","doi-asserted-by":"crossref","unstructured":"Stonehouse, W. (2014). Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials. Nutrients 6: 2730\u20132758.","DOI":"10.3390\/nu6072730"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_093","doi-asserted-by":"crossref","unstructured":"Su, H.M. (2010). Mechanisms of \u03c9-3 fatty acid-mediated development and maintenance of learning memory performance. J.\u00a0Nutr. Biochem. 21: 364\u2013373.","DOI":"10.1016\/j.jnutbio.2009.11.003"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_094","doi-asserted-by":"crossref","unstructured":"Su, K.P., Tseng, P.T., Lin, P.Y., Okubo, R., Chen, T.Y., Chen, Y.W., and Matsuoka, Y.J. (2018). Association of use of omega-3 polyunsaturated fatty acids with changes in severity of anxiety symptoms: a systematic review and meta-analysis. JAMA Netw. Open. 1: e182327.","DOI":"10.1001\/jamanetworkopen.2018.2327"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_095","doi-asserted-by":"crossref","unstructured":"Sublette, M.E., Ellis, S.P., Geant, A.L., and Mann, J.J. (2011). Meta-analysis of the effects of Eicosapentaenoic Acid (EPA) in clinical trials in depression. J.\u00a0Clin. Psychiatr. 72: 1577\u20131584.","DOI":"10.4088\/JCP.10m06634"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_096","doi-asserted-by":"crossref","unstructured":"Tabrizi, S.J., Ghosh, R., and Leavitt, B.R. (2019). Huntingtin lowering strategies for disease modification in Huntington\u2019s disease. Neuron 101: 801\u2013819.","DOI":"10.1016\/j.neuron.2019.01.039"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_097","doi-asserted-by":"crossref","unstructured":"Teixeira, A.L., de Souza, L.C., Rocha, N.P., Furr-Stimming, E., and Lauterbach, E.C. (2016). Revisiting the neuropsychiatry of Huntington\u2019s disease. Dement. Neurophsychol. 10: 261\u2013266.","DOI":"10.1590\/s1980-5764-2016dn1004002"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_098","doi-asserted-by":"crossref","unstructured":"Telenius, H., Kremer, H.P., Theilmann, J., Andrew, S.E., Almqvist, E., Anvret, M., Greenberg, C., Greenberg, J., Lucotte, G., Squitieri, F., et al.. (1993). Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum. Mol. Genet. 2: 1535\u20131540.","DOI":"10.1093\/hmg\/2.10.1535"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_099","doi-asserted-by":"crossref","unstructured":"Tereshchenko, A., Van Der Plas, E., Mathews, K.D., Epping, E., Conrad, A.L., Langbehn, D.R., and Nopoulos, P. (2020). Developmental trajectory of height, weight, and BMI in children and adolescents at risk for Huntington\u2019s disease: effect of mHTT on growth. J.\u00a0Huntingtons Dis. 9: 245\u2013251.","DOI":"10.3233\/JHD-200407"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_100","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72: 971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_101","doi-asserted-by":"crossref","unstructured":"Thesing, C.S., Bot, M., Milaneschi, Y., Giltay, E.J., and Penninx, B.W.J.H. (2018). Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders. Psychoneuroendocrinology 87: 53\u201362.","DOI":"10.1016\/j.psyneuen.2017.10.005"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_102","doi-asserted-by":"crossref","unstructured":"Trottier, Y., Devys, D., Imbert, G., Saudou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E.C., and Mandel, J.L. (1995). Cellular localization of the Huntington\u2019s disease protein and discrimination of the normal and mutated form. Nat. Genet. 10: 104\u2013110.","DOI":"10.1038\/ng0595-104"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_103","doi-asserted-by":"crossref","unstructured":"Trushina, E., Singh, R.D., Dyer, R.B., Cao, S., Shah, V.H., Parton, R.G., Pagano, R.E., and McMurray, C.T. (2006). Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum. Mol. Genet. 15: 3578\u20133591.","DOI":"10.1093\/hmg\/ddl434"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_104","doi-asserted-by":"crossref","unstructured":"Valenza, M. and Cattaneo, E. (2011). Emerging roles for cholesterol in Huntington\u2019s disease. Trends Neurosci. 34: 474\u2013486.","DOI":"10.1016\/j.tins.2011.06.005"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_105","doi-asserted-by":"crossref","unstructured":"Valenza, M., Chen, J.Y., Di Paolo, E., Ruozi, B., Belletti, D., Ferrari Bardile, C., Leoni, V., Caccia, C., Brilli, E., Di Donato, S., et al.. (2015). Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington\u2019s disease mice. EMBO Mol. Med. 7: 1547\u20131564.","DOI":"10.15252\/emmm.201505413"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_106","doi-asserted-by":"crossref","unstructured":"Valenza, M., Leoni, V., Karasinska, J.M., Petricca, L., Fan, J., Carroll, J., Pouladi, A.A., Fossale, E., Nguyen, H.P., Riess, O., et al.. (2010). Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J.\u00a0Neurosci. 30: 10844\u201310850.","DOI":"10.1523\/JNEUROSCI.0917-10.2010"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_107","doi-asserted-by":"crossref","unstructured":"van der Burg, J.M.M., Gardiner, S.L., Ludolph, A.C., Landwehrmeyer, G.B., Roos, R.A.C., and Aziz, N.A. (2017). Body weight is a robust predictor of clinical progression in Huntington disease. Ann. Neurol. 82: 479\u2013483.","DOI":"10.1002\/ana.25007"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_108","doi-asserted-by":"crossref","unstructured":"van Dijk, J.G., van der Velde, E.A., Roos, R.A., and Bruyn, G.W. (1986). Juvenile Huntington disease. Hum. Genet. 73: 235\u2013239.","DOI":"10.1007\/BF00401235"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_109","doi-asserted-by":"crossref","unstructured":"Vega, O.M., Abkenari, S., Tong, Z., Tedman, A., and Huerta-Yepez, S. (2020). Omega\u20103 polyunsaturated fatty acids and lung cancer: nutrition or pharmacology? Nutr. Canc. 1\u201321.","DOI":"10.1080\/01635581.2020.1761408"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_110","doi-asserted-by":"crossref","unstructured":"Waldvogel, H.J., Kim, E.H., Tippett, L.J., Vonsattel, J.P., and Faull, R.L. (2015). The neuropathology of Huntington\u2019s disease. Curr. Topics Behav. Neurosci. 22: 33\u201380.","DOI":"10.1007\/7854_2014_354"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_111","doi-asserted-by":"crossref","unstructured":"Wiktorowska-Owczarek, A., Berezi\u0144ska, M., and Nowak, J.Z. (2015). PUFAs: structures, metabolism and functions. Adv. Clin. Exp. Med. 24: 931\u2013941.","DOI":"10.17219\/acem\/31243"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_112","doi-asserted-by":"crossref","unstructured":"Wyant, K.J., Ridder, A.J., and Dayalu, P. (2017). Huntington\u2019s disease\u2014update on treatments. Curr. Neurol. Neurosci. Rep. 17: 33.","DOI":"10.1007\/s11910-017-0739-9"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_113","doi-asserted-by":"crossref","unstructured":"Yamamoto, A., Lucas, J.J., and Hen, R. (2000). Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 101: 57\u201366.","DOI":"10.1016\/S0092-8674(00)80623-6"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_114","doi-asserted-by":"crossref","unstructured":"Yu, M. and Bega, D. (2019). A review of the clinical evidence for complementary and alternative medicine in Huntington\u2019s disease. Tremor Other Hyperkinet. Mov. 9.","DOI":"10.5334\/tohm.509"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_115","doi-asserted-by":"crossref","unstructured":"Zielonka, D., Piotrowska, I., Marcinkowski, J.T., and Mielcarek, M. (2014). Skeletal muscle pathology in Huntington\u2019s disease. Front. Physiol. 5: 380.","DOI":"10.3389\/fphys.2014.00380"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_116","doi-asserted-by":"crossref","unstructured":"Zivkovic, A.M., Telis, N., German, J.B., and Hammock, B.D. (2011). Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health. Calif. Agric. 65: 106\u2013111.","DOI":"10.3733\/ca.v065n03p106"},{"key":"2023040102434497658_j_revneuro-2021-0013_ref_117","doi-asserted-by":"crossref","unstructured":"Zlokovic, B.V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 12: 723\u2013738.","DOI":"10.1038\/nrn3114"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2021-0013\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2021-0013\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T15:08:48Z","timestamp":1724771328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2021-0013\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,5]]},"references-count":117,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4,5]]},"published-print":{"date-parts":[[2021,12,20]]}},"alternative-id":["10.1515\/revneuro-2021-0013"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2021-0013","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,5]]}}}